ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 424

Influence of Pregnancy On Disease Activity-Associated Genes in Rheumatoid Arthritis

Erik J. Peterson1, Shreyasee Amin2, Hatice Bilgic3, Emily Baechler Gillespie3, Jane E. Salmon4, Ann M. Reed5, Weihua Guan6 and Daniel L. Mueller1, 1Medicine/Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, 2Division of Rheumatology, Mayo Clinic, Rochester, MN, 3University of Minnesota Medical School, Minneapolis, MN, 4Rheumatology, Hospital for Special Surgery, New York, NY, 5Rheumatology, Mayo Clinic, Rochester, MN, 6University of Minnesota School of Public Health, Minneapolis, MN

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: genomics, pregnancy and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) disease activity can often quiesce during pregnancy. Nevertheless, most women will experience a disease flare postpartum (PP). We hypothesized that changes in blood immune cell gene expression patterns during healthy pregnancy, which promote fetal tolerance in order to protect against fetal loss, will also be relevant in regulating RA disease activity.  

Methods:

Whole-blood gene expression profiles (15,050 expressed; p<0.05) from 19 pregnant RA subjects and 13 pregnant age-matched healthy controls (CON) were assayed at first trimester of pregnancy (T1), T2, T3, and PP using Illumina HumanHT-12 v3 and v4 BeadChip arrays. At identical time points, disease activity in RA women was assessed using the DAS28-CRP. A Generalized Estimating Equations (GEE) approach was applied to model gene expression changes during pregnancy (T1-T3) and between pregnancy and PP, to take into account the correlation within samples. A version effect (v3 vs v4) was also included in the model.

Results:

Within the CON samples, 581 blood cell genes demonstrated either a >20% change in mRNA expression between T1—>T2 or T2—>T3 of pregnancy, or a >20% change in expression between the average of T1—T3 and the PP period (BH q<0.05). Many of these genes mapped to Ingenuity Pathways associated with (p<0.01) hematopoietic system development and function (n=149 molecules), cell death (n=185), and immunological diseases (n=127). These 581 "pregnancy-related" genes were then selected for further study in the pregnant RA cohort. Of the 581 genes, 74 were found to be significantly associated with the DAS28-CRP score after correcting for multiple hypothesis tests (Bonferroni correction, p<8.6x10-5), with 11 of these demonstrating a >20% change in mRNA expression for every 1 unit change in DAS28-CRP score either during pregnancy or in the PP period. For the 50 pregnancy-related genes whose expression fell PP in association with rising DAS28-CRP, 7 genes (CD247, CD5, CD6, FLT3LG, IL7R, RBM38, and TUBB) were functionally associated with autoimmune diseases by Ingenuity Pathways Analysis; likewise, of the 24 genes whose expression directly correlated with DAS28-CRP PP, 5 genes (IL1B, MYD88, NCF4, PFKFB3, and SLC22A4) were associated with autoimmune diseases (p=0.0015).

Conclusion:

Our experiments identify 74 RA disease activity-correlated blood cell genes whose expression is modulated during normal pregnancy. Insofar as these genes reflect alterations in immune cell reactivity normally associated with pregnancy and promotion of fetal tolerance, they may represent a window into processes and pathways with a capacity to regulate disease activity in RA patients. Pregnancy-modulated genes that fluctuate with RA disease activity may also have utility as disease activity biomarkers.


Disclosure:

E. J. Peterson,
None;

S. Amin,
None;

H. Bilgic,
None;

E. Baechler Gillespie,
None;

J. E. Salmon,
None;

A. M. Reed,
None;

W. Guan,
None;

D. L. Mueller,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-pregnancy-on-disease-activity-associated-genes-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies